Cargando…

Emerging phagocytosis checkpoints in cancer immunotherapy

Cancer immunotherapy, mainly including immune checkpoints-targeted therapy and the adoptive transfer of engineered immune cells, has revolutionized the oncology landscape as it utilizes patients’ own immune systems in combating the cancer cells. Cancer cells escape immune surveillance by hijacking t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yu’e, Wang, Yanjin, Yang, Yanrong, Weng, Linjun, Wu, Qi, Zhang, Jin, Zhao, Pengcheng, Fang, Lan, Shi, Yufeng, Wang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990587/ https://www.ncbi.nlm.nih.gov/pubmed/36882399 http://dx.doi.org/10.1038/s41392-023-01365-z

Ejemplares similares

Co-delivery of phagocytosis checkpoint and STING agonist by a Trojan horse nanocapsule for orthotopic glioma immunotherapy
por: Zhou, Ying, et al.
Publicado: (2022)

Activation of phagocytosis by immune checkpoint blockade
por: Li, Chia-Wei, et al.
Publicado: (2018)

Dead cell phagocytosis and innate immune checkpoint
por: Yoon, Kyoung Wan
Publicado: (2017)

PD-L1 regulates genomic stability via interaction with cohesin-SA1 in the nucleus
por: Zhang, Wen, et al.
Publicado: (2021)

Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
por: Wang, Yuchen, et al.
Publicado: (2022)

Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors
por: Roy, Dia, et al.
Publicado: (2023)

IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy
por: Tang, Xi-Yang, et al.
Publicado: (2022)

A Pan-Cancer Immunogenomic Atlas for Immune Checkpoint Blockade Immunotherapy
por: Yang, Jing, et al.
Publicado: (2022)

Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
por: Arora, Sanjeevani, et al.
Publicado: (2019)

Transcriptional Regulation of Cancer Immune Checkpoints: Emerging Strategies for Immunotherapy
por: Venkatraman, Simran, et al.
Publicado: (2020)

Promoting antibody-dependent cellular phagocytosis for effective macrophage-based cancer immunotherapy
por: Cao, Xu, et al.
Publicado: (2022)

Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints
por: Shi, Tao, et al.
Publicado: (2018)

Nanobodies targeting immune checkpoint molecules for tumor immunotherapy and immunoimaging (Review)
por: Yu, Sheng, et al.
Publicado: (2021)

Response Prediction in Immune Checkpoint Inhibitor Immunotherapy for Advanced Hepatocellular Carcinoma
por: Hung, Hao-Chien, et al.
Publicado: (2021)

Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma
por: Qi, Xinmeng, et al.
Publicado: (2017)

Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy
por: Li, Guan-Zhang, et al.
Publicado: (2019)

Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
por: Zhao, Binghao, et al.
Publicado: (2022)

Anti–phagocytosis-blocking repolarization-resistant membrane-fusogenic liposome (ARMFUL) for adoptive cell immunotherapy
por: Zheng, Chunxiong, et al.
Publicado: (2023)

Research Progresses in Immunological Checkpoint Inhibitors for Breast Cancer Immunotherapy
por: Zhang, Wenxiang, et al.
Publicado: (2021)

Epigenetic checkpoint blockade: new booster for immunotherapy
por: Wang, Ziqiao, et al.
Publicado: (2021)

Multimodal Treatment Combining Salvage Surgery-Assisted Chemotherapy and Checkpoints Blockade Immunotherapy Achieves Complete Remission on a Recurrent Penile Cancer Patient: A Case Report
por: Hu, Linjun, et al.
Publicado: (2021)

Alternative Checkpoints as Targets for Immunotherapy
por: Pant, Ayush, et al.
Publicado: (2020)

Macrophage polarization synergizes with oxaliplatin in lung cancer immunotherapy via enhanced tumor cell phagocytosis
por: Li, Fei, et al.
Publicado: (2021)

Checkpoint therapeutic target database (CKTTD): the first comprehensive database for checkpoint targets and their modulators in cancer immunotherapy
por: Zhang, Yixiao, et al.
Publicado: (2020)

PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy
por: Tan, Kien Thiam, et al.
Publicado: (2020)

Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy
por: Wu, Jianmin, et al.
Publicado: (2021)

Microbial synthesis of Prussian blue for potentiating checkpoint blockade immunotherapy
por: Wang, Dongdong, et al.
Publicado: (2023)

Emerging Concepts in Defective Macrophage Phagocytosis in Cystic Fibrosis
por: Jaganathan, Devi, et al.
Publicado: (2022)

Emerging Blood-Based Biomarkers for Predicting Response to Checkpoint Immunotherapy in Non-Small-Cell Lung Cancer
por: Li, Shumin, et al.
Publicado: (2020)

Immune checkpoint inhibitors for multiple myeloma immunotherapy
por: Liu, Zhaoyun, et al.
Publicado: (2023)

The anti-B7-H4 checkpoint synergizes trastuzumab treatment to promote phagocytosis and eradicate breast cancer
por: Hu, Xiaochen, et al.
Publicado: (2020)

Targeting CD47-SIRPα axis for Hodgkin and non-Hodgkin lymphoma immunotherapy
por: Zhao, Pengcheng, et al.
Publicado: (2023)

Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy
por: Xu, Shumin, et al.
Publicado: (2023)

Innate immune checkpoints for cancer immunotherapy: expanding the scope of non T cell targets
por: Campesato, Luis F., et al.
Publicado: (2020)

Nanoparticle-Mediated In Situ Molecular Reprogramming of Immune Checkpoint Interactions for Cancer Immunotherapy
por: Walters, Adam A., et al.
Publicado: (2021)

Paraneoplastic Neurological Syndromes and Beyond Emerging With the Introduction of Immune Checkpoint Inhibitor Cancer Immunotherapy
por: Valencia-Sanchez, Cristina, et al.
Publicado: (2021)

Phagocytosis
Publicado: (1892)

On Phagocytosis
Publicado: (1907)

Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer
por: Shang, Yufeng, et al.
Publicado: (2019)

Deciphering the role of QPCTL in glioma progression and cancer immunotherapy
por: Liu, Yu’e, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6jgh5f7vjvn0ttrs6k1a8n2rcd